Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
暂无分享,去创建一个
G. Leverger | D. Frappaz | L. de Lumley | J. Michon | F. Millot | P. Lutz | G. Margueritte | D. Plantaz | O. Hartmann | H. Rubié | P. Chastagner | C. Coze | Y. Pérel | M. Baranzelli | M. Peyroulet | F. Méchinaud | P. Boutard | J. L. Stéphan
[1] D. Frappaz,et al. The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease: A prospective study of 42 patients‐‐Results of the NBL 90 study of the French Society of Pediatric Oncology , 1996, Cancer.
[2] A. Donfrancesco,et al. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Look,et al. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. , 1995, Cancer research.
[4] A. Donfrancesco,et al. Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] F. Berthold,et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. , 1993, Progress in clinical and biological research.
[6] D. Frappaz,et al. Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Nakagawara,et al. Neuroblastoma: Effect of genetic factors on prognosis and treatment , 1992, Cancer.
[8] M. Kaneko,et al. Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan. , 1992, Journal of pediatric surgery.
[9] J. Shuster,et al. A population-based study of neuroblastoma incidence, survival, and mortality in North America. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Shuster,et al. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] H. Sather,et al. A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] H. Sather,et al. Improvement in survival after excision of primary tumor in stage III neuroblastoma. , 1989, Journal of pediatric surgery.
[13] K. Matthay,et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] H. Sather,et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.
[15] J. Bernard,et al. Evaluation of the role of surgery in 130 patients with neuroblastoma. , 1985, Journal of pediatric surgery.
[16] S. Sallan,et al. Improved survival in neuroblastoma using multimodality therapy. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] S. Sallan,et al. Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] C. Koop,et al. The role of multimodal therapy in patients with local and regional neuroblastoma. , 1984, Journal of pediatric surgery.
[19] J. Mann,et al. Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. , 1982, Archives of disease in childhood.
[20] V. Castel,et al. Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. , 1995, Medical and pediatric oncology.
[21] B. Korf,et al. Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Grosfeld,et al. Stage II neuroblastoma--does adjuvant irradiation contribute to cure? , 1985, Medical and pediatric oncology.
[23] S. Sallan,et al. Influence of local-regional lymph node metastases on prognosis in neuroblastoma. , 1984, Medical and pediatric oncology.